Tezepelumab

Tezepelumab, sold under the brand name Tezspire, is a human monoclonal antibody used for the treatment of asthma.[4][5] It blocks thymic stromal lymphopoietin (TSLP),[2] an epithelial cytokine that has been suggested to be critical in the initiation and persistence of airway inflammation.[6] It was approved for medical use in the United States in December 2021.[2][3] Contents 1 Medical uses 2 Re... [wikipedia]